Résultats de la recherche

Radiance Biopharma Enters Exclusive License For ROR-1 Targeted Antibody Drug Conjugate BOSTON, Massachusetts, Feb. 19, 2025 (GLOBE NEWSWIRE) -- Radiance Biopharma, Inc., ("Radiance" or the "Company"), a biotechnology company, today announced that it has entered into an exclusive...